Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low dose versus moderate dose prednisolone in acute CPPD
TCTR20211224003Phase 3Recruiting
- Sponsor
- Vajira Hospital
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in chondrocalcinosis (CPPD), sponsored by Vajira Hospital. Started Nov 2021; status: recruiting.
02
Drugs
prednisolone
03
Conditions
chondrocalcinosis (CPPD)
Beyond the preview
Go deeper on TCTR20211224003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211224003.